|
US4311698A
(en)
|
1979-03-12 |
1982-01-19 |
Haskell Theodore H |
Aminoacid derivatives of cephalosporin compounds
|
|
US4278681A
(en)
|
1979-03-12 |
1981-07-14 |
Warner-Lambert Co. |
Antibacterial amide compounds and means for using the same
|
|
JPS56115784A
(en)
|
1980-02-15 |
1981-09-11 |
Tanabe Seiyaku Co Ltd |
Novel pyridinecarboxamide derivative and its preparation
|
|
US4315014A
(en)
|
1980-09-24 |
1982-02-09 |
Warner-Lambert Company |
Antibacterial amide compounds and pharmaceutical composition containing the same
|
|
US4315858A
(en)
|
1980-09-24 |
1982-02-16 |
Warner-Lambert Company |
Antibacterial amide compounds
|
|
JPH02127512A
(ja)
|
1988-11-07 |
1990-05-16 |
Motoo Takayanagi |
ピラジン環含有芳香族ポリアミド繊維
|
|
JPH02127429A
(ja)
|
1988-11-07 |
1990-05-16 |
Motoo Takayanagi |
ピラジン環含有芳香族ポリアミドおよびその製造法
|
|
GB2273930A
(en)
*
|
1992-12-30 |
1994-07-06 |
Glaxo Group Ltd |
Benzanilide derivatives
|
|
US5563143A
(en)
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
|
DE19624668A1
(de)
|
1996-06-20 |
1998-02-19 |
Klinge Co Chem Pharm Fab |
Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden
|
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
JP3354090B2
(ja)
|
1996-09-30 |
2002-12-09 |
シエーリング アクチエンゲゼルシャフト |
分化誘導剤
|
|
JP4405602B2
(ja)
|
1998-04-16 |
2010-01-27 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ヒストン脱アセチル化酵素阻害剤
|
|
JP2000256194A
(ja)
|
1999-01-06 |
2000-09-19 |
Mitsui Chemicals Inc |
核内レセプタ作動薬およびその効果増強剤
|
|
AU7278500A
(en)
|
1999-08-18 |
2001-03-13 |
Aventis Cropscience Gmbh |
Fungicides
|
|
EE200300360A
(et)
*
|
2001-01-31 |
2003-12-15 |
Pfizer Products Inc. |
PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
|
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
|
WO2003003008A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Chemical libraries useful for drug discovery processes
|
|
WO2003055477A1
(en)
|
2001-12-21 |
2003-07-10 |
7Tm Pharma A/S |
Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
|
|
JP4505228B2
(ja)
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Ｒｈｏ−キナーゼ阻害剤
|
|
EP1348434A1
(en)
|
2002-03-27 |
2003-10-01 |
Fujisawa Deutschland GmbH |
Use of pyridyl amides as inhibitors of angiogenesis
|
|
EP1738752A1
(en)
|
2002-12-27 |
2007-01-03 |
Schering Aktiengesellschaft |
Pharmaceutical combinations comprising cis-retine acid
|
|
DE10334724A1
(de)
*
|
2003-07-30 |
2005-02-24 |
Bayer Healthcare Ag |
N-Biarylamide
|
|
JP2008510726A
(ja)
*
|
2004-08-20 |
2008-04-10 |
エントレメッド インコーポレイテッド |
プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
|
|
ES2377430T3
(es)
|
2004-09-02 |
2012-03-27 |
Genentech, Inc. |
Inhibidores piridílicos de la señalización de hedgehog
|
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
|
CN101128454A
(zh)
|
2004-12-22 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
用作抗癌药物的吡啶羧酰胺衍生物
|
|
JP2008545744A
(ja)
|
2005-06-02 |
2008-12-18 |
バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト |
フェニルアルキル置換ヘテロアリール誘導体
|
|
BRPI0615133A2
(pt)
|
2005-08-23 |
2011-05-03 |
Irm Llc |
compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
|
|
CA2630639A1
(en)
|
2005-11-21 |
2007-05-31 |
Tap Pharmaceutical Products, Inc. |
Treatment of qt interval prolongation and diseases associated therewith
|
|
TWI372752B
(en)
|
2005-12-22 |
2012-09-21 |
Nihon Nohyaku Co Ltd |
Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
|
|
WO2007076055A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
AU2006336504C9
(en)
|
2005-12-28 |
2015-05-14 |
Vertex Pharmaceuticals Incorporated |
1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
|
|
JP2009534458A
(ja)
|
2006-04-26 |
2009-09-24 |
キャンサー・リサーチ・テクノロジー・リミテッド |
アミノ−エチル−アミノ−アリール（ａｅａａ）化合物およびそれらの使用
|
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
|
FR2904827B1
(fr)
|
2006-08-11 |
2008-09-19 |
Sanofi Aventis Sa |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii
|
|
WO2008024963A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Benzene, pyridine, and pyridazine derivatives
|
|
WO2008026018A1
(en)
|
2006-09-01 |
2008-03-06 |
Topotarget Switzerland Sa |
New method for the treatment of inflammatory diseases
|
|
FR2921657A1
(fr)
*
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
|
US8324226B2
(en)
|
2007-10-24 |
2012-12-04 |
Cancer Research Technology Limited |
Therapeutic oxy-phenyl-aryl compounds and their use
|
|
CA2705848C
(en)
|
2007-11-21 |
2016-02-02 |
Bio-Rad Laboratories, Inc. |
Photoluminescent metal complexes for protein staining
|
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
|
EP2639224B1
(en)
|
2007-12-07 |
2016-08-24 |
Vertex Pharmaceuticals Incorporated |
Process for producing cycloalkylcarboxiamido-pyridine benzoic acids
|
|
EP2098231A1
(en)
|
2008-03-05 |
2009-09-09 |
Topotarget Switzerland SA |
Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury
|
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
US20110098311A1
(en)
*
|
2009-10-22 |
2011-04-28 |
Vertex Pharmaceuticals Incorported |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
UY33469A
(es)
*
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
US20130109682A1
(en)
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
|
WO2012054110A2
(en)
|
2010-07-07 |
2012-04-26 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP2591354B1
(en)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
DK2599771T3
(en)
|
2010-07-30 |
2016-10-24 |
Daito Chemix Corp |
naphthalene
|
|
WO2012024179A1
(en)
|
2010-08-18 |
2012-02-23 |
Merck Sharp & Dohme Corp. |
Substituted amide derivatives as dgat-1 inhibitors
|
|
EP2611804A1
(en)
|
2010-09-03 |
2013-07-10 |
Forma TM, LLC. |
Novel compounds and compositions for the inhibition of nampt
|
|
JP5822840B2
(ja)
|
2010-09-30 |
2015-11-24 |
ダイトーケミックス株式会社 |
眼疾患処置薬
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
CA2836338C
(en)
|
2011-05-16 |
2022-05-03 |
Koninklijke Philips N.V. |
Tetrazine derivatives used in bio-orthogonal drug activation
|
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
|
EP2739144A4
(en)
|
2011-06-20 |
2015-04-01 |
Alzheimer S Inst Of America Inc |
COMPOUNDS AND ITS THERAPEUTIC USE
|
|
WO2013028445A1
(en)
*
|
2011-08-19 |
2013-02-28 |
Glaxosmithkline Llc |
Fatty acid synthase inhibitors
|
|
EP2589292A1
(en)
|
2011-11-02 |
2013-05-08 |
Bayer CropScience AG |
Compounds with nematicidal activity
|
|
EP2773203A1
(en)
|
2011-11-02 |
2014-09-10 |
Bayer Intellectual Property GmbH |
Compounds with nematicidal activity
|
|
GB201120993D0
(en)
|
2011-12-06 |
2012-01-18 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
AR091654A1
(es)
|
2012-07-02 |
2015-02-18 |
Biogen Idec Inc |
COMPUESTOS QUE CONTIENEN BIARILO COMO AGONISTAS INVERSOS DE RECEPTORES ROR-g
|
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
|
FI2922574T3
(fi)
|
2012-11-22 |
2023-08-11 |
Tagworks Pharmaceuticals B V |
Kemiallisesti pilkkoutuva ryhmä
|
|
JP5799117B2
(ja)
|
2013-02-05 |
2015-10-21 |
大日本住友製薬株式会社 |
ウラシル誘導体からなる医薬
|
|
WO2014145873A2
(en)
|
2013-03-15 |
2014-09-18 |
Epigen Biosciences, Inc. |
Heterocyclic compounds useful in the treatment of disease
|
|
US20160046616A1
(en)
*
|
2013-03-15 |
2016-02-18 |
The Johns Hopkins University |
Nrf2 small molecule inhibitors for cancer therapy
|
|
WO2014203217A1
(en)
*
|
2013-06-21 |
2014-12-24 |
Lupin Limited |
Substituted heterocyclic compounds as crac modulators
|
|
GB201316823D0
(en)
*
|
2013-09-23 |
2013-11-06 |
R & D Vernalis Ltd |
New Chemical Entities
|
|
EP3099677A4
(en)
|
2014-01-31 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
KR102265277B1
(ko)
|
2014-04-11 |
2021-06-16 |
판옵테스 파르마 게스.엠.베.하. |
바이러스 억제 화합물로서의 항-염증제
|
|
TW201625641A
(zh)
|
2014-05-22 |
2016-07-16 |
健臻公司 |
Ｎａｍｐｔ抑制劑及方法
|
|
WO2017009650A1
(en)
|
2015-07-14 |
2017-01-19 |
Mission Therapeutics Limited |
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
|
|
WO2017106436A1
(en)
*
|
2015-12-15 |
2017-06-22 |
University Of Miami |
Inhibitors of tnf superfamily costimulatory interactions and methods for uses of the same
|
|
GB201602854D0
(en)
*
|
2016-02-18 |
2016-04-06 |
Mission Therapeutics Ltd |
Novel compounds
|
|
CN108713013B
(zh)
|
2016-02-29 |
2021-06-18 |
住友化学株式会社 |
杂环化合物
|
|
WO2017160116A2
(ko)
|
2016-03-17 |
2017-09-21 |
연세대학교 산학협력단 |
니코틴아미드 포스포리보실트랜스퍼라제 억제용 신규 화합물 및 이를 포함하는 조성물
|
|
US10398783B2
(en)
|
2016-10-20 |
2019-09-03 |
Bristol-Myers Squibb Company |
Antiproliferative compounds and conjugates made therefrom
|
|
WO2018101424A1
(ja)
|
2016-12-01 |
2018-06-07 |
住友化学株式会社 |
複素環化合物及びそれを含有する有害節足動物防除組成物
|
|
CN108314677B
(zh)
|
2017-01-17 |
2020-06-30 |
安徽中科拓苒药物科学研究有限公司 |
一种ezh2抑制剂及其用途
|
|
BR112019021388B1
(pt)
|
2017-04-11 |
2023-10-31 |
Mitsui Chemicals Crop & Life Solutions, Inc |
Compostos, agente de controle de pragas agrícolas e hortícolas, fungicida agrícola e hortícola e métodos para prevenção e/ou tratamento de uma doença de plantas
|
|
JP7211358B2
(ja)
|
2017-05-22 |
2023-01-24 |
小野薬品工業株式会社 |
Ｅｐ４アンタゴニスト
|
|
EP3746070A4
(en)
|
2018-01-29 |
2021-09-01 |
Capulus Therapeutics, LLC |
SREBP INHIBITORS WITH A 6-LINKED CENTER RING
|
|
US12522587B2
(en)
|
2018-05-04 |
2026-01-13 |
Remedy Plan, Inc. |
Cancer treatments targeting cancer stem cells
|
|
JP7399589B2
(ja)
|
2018-09-12 |
2023-12-18 |
日本化薬株式会社 |
有害生物防除剤
|
|
EP4055008A1
(en)
|
2019-11-06 |
2022-09-14 |
Remedy Plan, Inc. |
Cancer treatments targeting cancer stem cells
|
|
KR102210267B1
(ko)
|
2020-05-26 |
2021-02-01 |
(주)피엔에이치테크 |
유기발광 화합물 및 이를 포함하는 유기발광소자
|
|
KR20230061442A
(ko)
|
2020-09-02 |
2023-05-08 |
도꾜 다이가꾸 |
유기 반도체 재료
|
|
JP2024518089A
(ja)
|
2021-05-13 |
2024-04-24 |
リメディー プラン，インコーポレーテッド |
Ｎａｍｐｔ阻害剤とその使用
|